My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
August-September 2013
Top Stories
CDC Report Puts Spotlight on Threat of Antibiotic Resistance

This month the Centers for Disease Control and Prevention (CDC) released a report entitled, “Antibiotic Resistance Threats in the United States, 2013” in which they recommend four core actions to stop the spread of resistance:  preventing infections, tracking resistant germs, improving use of antibiotics (stewardship), and finding new drugs and diagnostics. These actions are closely aligned with the goals of IDSA, and IDSA has been working with the CDC, congressional champions and coalition partners to build upon the momentum generated by this report and spur meaningful policy actions.

During a congressional briefing co-hosted by IDSA, CDC and the Pew Charitable Trusts to highlight this report for lawmakers, IDSA President David Relman spoke about the need for Congress to combat antibiotic resistance by enacting the Strategies to Address Antimicrobial Resistance (STAAR) Act, which would improve federal leadership, surveillance, data collection and research; and providing incentives to spur antibiotic research and development, including the Limited Population Antibacterial Drug (LPAD) approval mechanism, an expedited pathway to the Food and Drug Administration (FDA) approval for antibiotics that treat serious or life-threatening infections for which there are currently few or no treatment options.  He also noted that the budgets for CDC and other agencies addressing these issues are at the lowest level in a decade.  Increased funding is needed for advanced molecular detection, diagnostics, and antibiotic stewardship.  Diagnostic tools play a very important role in addressing resistance in multiple ways, including guiding appropriate antibiotic use and helping to identify patients for antibiotic clinical trials.

The CDC report increases awareness of the threat that antibiotic resistance poses and encourages immediate action to address the potentially catastrophic threat. The CDC estimates in its report that in the United States, more than 2 million people are sickened every year with antibiotic-resistant infections, with at least 23,000 dying as a result. The number of Clostridium difficile infections is estimated to be at least one-quarter million with at least 14,000 deaths. (Although the report notes that C. difficile infections are not yet significantly resistant to the drugs used to treat them, most cases are directly related to antibiotic use.)  CDC’s estimates are based on conservative assumptions and are likely minimum estimates.  IDSA continues to advocate for improved surveillance and data collection activities to more accurately capture the significant burden of resistant infections. 

For the first time, the CDC prioritized bacteria in the report into one of three categories: urgent, serious, and concerning. Those listed as urgent are: Clostridium difficile (C diff.), carbapenem-resistant Enterobacteriaceae (CRE), and drug-resistant Neisseria gonorrhoeae.

The report generated significant media coverage, much of which included input and quotes from IDSA members. Finally estimating the problem sends a "very powerful message," said IDSA Board member Helen Boucher, MD, FIDSA, in an Associated Press article.

IDSA will continue advocating for the Society’s policy priorities to address antibiotic resistance, incentivize the development of new antimicrobial drugs and diagnostics, and promote their appropriate use. You can help us now by taking a minute or two to contact your congressional representatives and urge them to cosponsor the STAAR Act. 
How useful is this article?

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:

Patient Care and Science
IDSA Joins Forces with AASLD to Develop Hepatitis C Practice Recommendations
FDA Permits Marketing of First U.S. Test Labeled for Simultaneous Detection of TB Bacteria and Resistance to the Antiobiotice Rifampin
Clinical Practice Management
AMA Toolkit Now Available on Compliance for Revised HIPPA Rules
Health Care Reform Implementation Resources for Clinicians
Global ID
Congressional Staffers See ID Strides in Africa HIV/TB Responses
Science Speaks Blog
Kasisi Children’s Home: “Because of You We Can Help the Children.”
Short-Staffed Durban Clinic Raises Question: What is the Cost of Waiting?
At Urban Crossroads, Research, Care and Community Meet
Facing Transition to “Country Ownership,” Civil Society Representatives Highlight Populations’ Diverse Needs, Common Goals
You and Your Colleagues
In Memoriam: Morton N. Swartz, MD, FIDSA (1923-2013)
IDSA Congratulates 2013 Joint Research Award Winners
Check Out “My IDSA” for Latest Member News
Education and Resources
IDSA Offering New Maintenance of Certification Modules in HIV and HCV
Top Stories
IDSA/Avalere Study Demonstrates the Value of the ID Specialist
From the President: Year in Review
CDC Report Puts Spotlight on Threat of Antibiotic Resistance
IDSA Journal Club

IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add '' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.